Table 6.

Twelve deceased patients.

Case no./References	Age/Sex	Disseminated or not	Immune status	Treatment	Cause of death
1/ Chleboun and Nade, 1977	43/M	No	Relatively immunocompromised	Surgery	Unknown
4/ Chleboun and Nade, 1977	15/M	No	Immunocompetent	AMB395 mg	Tuberculous hepatitis and staphylococcal pneumonia
12/ Heenan and Dawkins, 1981	54/M	Yes	Classically immunodeficient	Surgery AMB+5-FC2700 g	Unknown
16/ Cash and Goodman, 1983	59/M	CNS	Relatively immunocompromised	AMB+5-FC	Cardiorespiratory arrest on the 13th day of therapy
17/ Perfect et al., 1983	46/F	CNS, skin, blood	Classically immunodeficient	AMB+5-FC	Serratia septicemia
18/ Perfect et al., 1983	32/F	Retina, CNS, urine, blood	Classically immunodeficient	AMB	Unknown
21/ Reinig et al., 1984	10/F	No	Classically immunodeficient	Surgery AMB+5-FC	Respiratory failure
27/ Ricciardi et al., 1986	37/M	CNS, skin, blood	Classically immunodeficient	AMB+5-FC	Unknown
54/ Liu, 1998	60/M	Yes	Relatively immunocompromised	Surgery AMB	Severe hepatic failure
65/ Gupta et al., 2003	24/F	Yes	Relatively immunocompromised	Surgery AMB+5-FC	Cryptococcosis
70/ Goldshteyn et al., 2006	84/F	CNS	Classically immunodeficient	Surgery×2 AMB+5-FC+Flu	Unknown
77/ Agadi et al., 2010	29/F	Yes	Relatively immunocompromised	AMB	Cardiac failure

AMB, amphotericin B; 5-FC, 5-fluorocytosine; Flu, fluconazole.